Example: bankruptcy

2018 CPT Code Changes Cytopathology CPT Code …

CPT CodeNew/ revised /DeletedDescriptionG0364 DeletedBone marrow aspirate & biopsy38222 NewDiagnostic bone marrow; biopsy(ies) and aspirations(s)88154 Deletedwith manual screening and computer-assisted rescreening using cell selection and review under physician supervisionCPT CodeNew/ revised /DeletedDescription82043 Revisedurine (eg, microalbumin), quantitative82044 Revisedurine (eg, microalbumin), semiquantitative (eg, reagent strip assay)82042 Revisedother source, quantitative, each specimen83499 DeletedHydroxyprogesterone, 20-84061 Deletedforensic examinationCPT CodeNew/ revised /DeletedDescription86003 RevisedAllergen specific IgE; quantitative or semiquantitative, crude allergen extract, each86005 Revisedqualitative, multiallergen screen (eg, disk, sponge, card)86008 NewAllergen specific IgE; quantitative or semiquantitative, recombinant or purified component, each86185 DeletedCounterimmunoelectrophoresis, each antigen86243 DeletedFc receptor86378 DeletedMigration inhibitory factor test (MIF)86729 Deletedlymphogranuloma vener

CPT Code New/Revised/Deleted Description Revised now 81232 DPYD (dihydropyrimidine dehydrogenase) (eg, 5-fluorouracil/5-FU and capecitabine drug metabolism),

Tags:

  Code, Descriptions, Revised, Cpt codes, Deleted, Cpt code new revised deleted description revised

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Advertisement

Transcription of 2018 CPT Code Changes Cytopathology CPT Code …

1 CPT CodeNew/ revised /DeletedDescriptionG0364 DeletedBone marrow aspirate & biopsy38222 NewDiagnostic bone marrow; biopsy(ies) and aspirations(s)88154 Deletedwith manual screening and computer-assisted rescreening using cell selection and review under physician supervisionCPT CodeNew/ revised /DeletedDescription82043 Revisedurine (eg, microalbumin), quantitative82044 Revisedurine (eg, microalbumin), semiquantitative (eg, reagent strip assay)82042 Revisedother source, quantitative, each specimen83499 DeletedHydroxyprogesterone, 20-84061 Deletedforensic examinationCPT CodeNew/ revised /DeletedDescription86003 RevisedAllergen specific IgE; quantitative or semiquantitative, crude allergen extract, each86005 Revisedqualitative, multiallergen screen (eg, disk, sponge, card)86008 NewAllergen specific IgE; quantitative or semiquantitative, recombinant or purified component, each86185 DeletedCounterimmunoelectrophoresis, each antigen86243 DeletedFc receptor86378 DeletedMigration inhibitory factor test (MIF)86729 Deletedlymphogranuloma venereum86794 NewZika virus, IgMCPT CodeNew/ revised /DeletedDescription86822 Deletedlymphocyte culture, primed (PLC)CPT CodeNew/ revised /DeletedDescription87277 DeletedLegionella micdadei87470 DeletedInfectious agent detection by nucleic acid (DNA or RNA).

2 Bartonella henselae and Bartonella quintana, direct probe technique2018 CPT code ChangesCytopathology Chemistry Immunology Tissue TypingMicrobiology87477 DeletedBorrelia burgdorferi, quantification87515 Deletedhepatitis B virus, direct probe technique87634 NewInfectious agent detection by nucleic acid (DNA or RNA); respiratory syncytial virus, amplified probe technique87662 NewInfectious agent detection by nucleic acid (DNA or RNA); Zika virus, amplified probe techniqueCPT CodeNew/ revised /DeletedDescriptionG0499 NewHepatitis B screening in non-pregnant, high risk individual includes hepatitis B surface antigen (HBsAg) followed by a neutralizing confirmatory test for initially reactive results, and antibodies to HBsAg (anti-HBs) and hepatitis B core antigen (anti-HBc)CPT CodeNew/ revised /DeletedDescription81175 NewASXL1 (additional sex combs like 1, transcriptional regulator) (eg, myelodysplastic syndrome, myeloproliferative neoplasms, chronic myelomonocytic leukemia) gene analysis.

3 Full gene sequence81176 NewASXL1 (additional sex combs like 1, transcriptional regulator) (eg, myelodysplastic syndrome, myeloproliferative neoplasms, chronic myelomonocytic leukemia) gene analysis; targeted sequence analysis (eg, exon 12)81230 Newwas 81401 CYP3A4 (cytochrome P450 family 3 subfamily A member 4) (eg, drug metabolism) gene analysis, common variant(s) (eg, *2, *22)81231 Newwas 81401 CYP3A5 (cytochrome P450 family 3 subfamily A member 5) (eg, drug metabolism) gene analysis, common variants (eg, *2, *3, *4, *5 *6, *7)81232 Newwas 81400 DPYD (dihydropyrimidine dehydrogenase) (eg, 5-fluorouracil/5-FU and capecitabine drug metabolism) gene analysis, common variant(s) (eg, *2A, *4, *5, *6)81238 Newwas 81405F9 (coagulation factor IX) (eg, hemophilia B) full gene sequence81247 NewG6PD (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice) gene analysis.

4 Common variant(s) (eg, A, A-)81248 NewG6PD (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice) gene analysis; known familial variant(s)81249 NewG6PD (glucose-6-phosphate dehydrogenase) (eg, hemolytic anemia, jaundice) gene analysis; full gene sequence Tier 1 Molecular Pathology Other81257 RevisedHBA1/HBA2 (alpha globin 1 and alpha globin 2)(eg, alpha thalassemia, Hb Bart hydrops fetalis syndrome, HbH disease), gene analysis; common deletions or variant (eg, Southeast Asian, Thai, Filipino, Mediterranean, , , , and Constant Spring)81258 NewHBA1/HBA2 (alpha globin 1 and alpha globin 2) (eg, alpha thalassemia, Hb Bart hydrops fetalis syndrome, HbH disease), gene analysis; known familial variant81259 Newwas 81405 HBA1/HBA2 (alpha globin 1 and alpha globin 2) (eg, alpha thalassemia, Hb Bart hydrops fetalis syndrome, HbH disease), gene analysis; full gene sequence81269 Newwas 81404 HBA1/HBA2 (alpha globin 1 and alpha globin 2) (eg, alpha thalassemia, Hb Bart hydrops fetalis syndrome, HbH disease), gene analysis.

5 Duplication/deletion variants81105 Newwas 81400 Human Platelet Antigen 1 genotyping (HPA-1), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa], antigen CD61 [GPIIIa]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura) gene analysis, common variant, HPA-1a/b (L33P)81106 Newwas 81400 Human Platelet Antigen 2 genotyping (HPA-2), GP1BA (glycoprotein Ib [platelet], alpha polypeptide [GPIba]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura) gene analysis, common variant, HPA-2a/b (T145M)81107 Newwas 81400 Human Platelet Antigen 3 genotyping (HPA-3), ITGA2B (integrin, alpha 2b [platelet glycoprotein IIb of IIb/IIIa complex], antigen CD41 [GPIIb]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura) gene analysis, common variant, HPA-3a/b (I843S)81108 Newwas 81400 Human Platelet Antigen 4 genotyping (HPA-4), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa], antigen CD61 [GPIIIa]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura) gene analysis, common variant, HPA-4a/b (R143Q)81109 Newwas 81400 Human Platelet Antigen 5 genotyping (HPA-5), ITGA2 (integrin, alpha 2 [CD49B, alpha 2 subunit of VLA-2 receptor] [GPIa])

6 (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura) gene analysis, common variant (eg, HPA-5a/b (K505E))81110 Newwas 81400 Human Platelet Antigen 6 genotyping (HPA-6w), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa, antigen CD61] [GPIIIa]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura) gene analysis, common variant, HPA-6a/b (R489Q)81111 Newwas 81400 Human Platelet Antigen 9 genotyping (HPA-9w), ITGA2B (integrin, alpha 2b [platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41] [GPIIb]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura) gene analysis, common variant, HPA-9a/b (V837M)81112 Newwas 81400 Human Platelet Antigen 15 genotyping (HPA-15), CD109 (CD109 molecule) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura) gene analysis, common variant, HPA-15a/b (S682Y)81120 Newwas 81403 IDH1 (isocitrate dehydrogenase 1 [NADP+], soluble) (eg, glioma), common variants (eg, R132H, R132C)81121 Newwas 81403 IDH2 (isocitrate dehydrogenase 2 [NADP+], mitochondrial) (eg, glioma), common variants (eg, R140W, R172M)81283 Newwas 81400 IFNL3 (interferon, lambda 3) (eg, drug response) gene analysis, rs12979860 variant81334 NewRUNX1 (runt related transcription factor 1)

7 (eg, acute myeloid leukemia, familial platelet disorder with associated myeloid malignancy) gene analysis, targeted sequence analysis (eg, exons 3-8)81328 Newwas 81400 SLCO1B1 (solute carrier organic anion transporter family, member 1B1) (eg, adverse drug reaction) gene analysis, common variant(s) (eg, *5)81335 Newwas 81401 TPMT (thiopurine S-methyltransferase) (eg, drug metabolism) gene analysis, common variants (eg, *2, *3)81346 Newwas 81401 TYMS (thymidylate synthetase) (eg, 5-fluorouracil/5-FU drug metabolism) gene analysis, common variant(s) (eg, tandem repeat variant)81361 Newwas 81401 HBB (hemoglobin, subunit beta) (eg, sickle cell anemia, beta thalassemia, hemoglobinopathy); common variant(s) (eg, HbS, HbC, HbE)81362 Newwas 81401 HBB (hemoglobin, subunit beta) (eg, sickle cell anemia, beta thalassemia, hemoglobinopathy); known familial variant(s)81363 Newwas 81403 HBB (hemoglobin, subunit beta) (eg, sickle cell anemia, beta thalassemia, hemoglobinopathy); duplication/deletion variant(s)81364 Newwas 81404 HBB (hemoglobin, subunit beta) (eg, sickle cell anemia, beta thalassemia, hemoglobinopathy).

8 Full gene sequenceCPT CodeNew/ revised /DeletedDescriptionRevise dnow 81232 DPYD (dihydropyrimidine dehydrogenase) (eg, 5-fluorouracil/5-FU and capecitabine drug metabolism), IVS14+1G>A variantRevisednow 81105 Human Platelet Antigen 1 genotyping (HPA-1), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa], antigen CD61 [GPIIIa]) (eg,neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), HPA-1a/b (L33P)Revisednow 81106 Human Platelet Antigen 2 genotyping (HPA-2), GP1BA (glycoprotein Ib [platelet], alpha polypeptide [GPIba]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), HPA-2a/b (T145M)Revisednow 81107 Human Platelet Antigen 3 genotyping (HPA-3), ITGA2B (integrin, alpha 2b [platelet glycoprotein IIb of IIb/IIIa complex], antigen CD41 [GPIIb]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), HPA-3a/b (I843S)Revisednow 81108 Human Platelet Antigen 4 genotyping (HPA-4), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa], antigen CD61 [GPIIIa]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), HPA-4a/b (R143Q)Revisednow 81109 Human Platelet Antigen 5 genotyping (HPA-5), ITGA2 (integrin, alpha 2 [CD49B, alpha 2 subunit of VLA-2 receptor] [GPIa])

9 (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), HPA-5a/b (K505E)Revisednow 81110 Human Platelet Antigen 6 genotyping (HPA-6w), ITGB3 (integrin, beta 3 [platelet glycoprotein IIIa, antigen CD61] [GPIIIa]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), HPA-6a/b (R489Q)Revisednow 81111 Human Platelet Antigen 9 genotyping (HPA-9w), ITGA2B (integrin, alpha 2b [platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41] [GPIIb]) (eg, neonatal alloimmune thrombocytopenia [NAIT], post-transfusion purpura), HPA-9a/b (V837M)RevisedMolecular pathology procedure, Level 2 (eg, 2-10 SNPs, 1 methylated variant, or 1 somatic variant {typically using nonsequencing target variant analysis}, or detection of a dynamic mutation disorder/triplet repeat)Revisednow 81230 CYP3A4 (cytochrome P450, family 3, subfamily A, polypeptide 4) (eg, drug metabolism), common variants (eg, *2, *3, *4, *5, *6)Revisednow 81231 CYP3A5 (cytochrome P450, family 3, subfamily A, polypeptide 5) (eg, drug metabolism), common variants (eg, *2, *3, *4, *5, *6)

10 Tier 2 Molecular Pathology 81400 RevisedMolecular pathology procedure, Level 1 (eg, identification of single germline variant [eg, SNP] by techniques such as restriction enzyme digestion or melt curve analysis)


Related search queries